Meta Pixel

News and Announcements

Bhumi to launch equity crowdfunding campaign next month

  • Published January 18, 2019 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

KEY TAKEAWAYS:

  • Bhumi have decided to revisit capital raising and will launch an equity crowdfunding campaign this year.
  • The company are working closely with Birchal to initiate the campaign.
  • Bhumi will be revisiting the capital raise that they did not close last year.

Bhumi will be launching an equity crowdfunding campaign this year.

The company are working closely with Birchal, a new equity crowdfunding platform connecting brands with investors, to initiate the campaign.

Co-Founder, Dushyant, said: “It’s time for us to revisit the capital raise activity which we had started and were close to completing, but did not end up closing on the Convertible Note last year.”

The Birchal platform makes the actual review of the offer and subsequent transaction easier for the investors.

 

About Bhumi

Bhumi was founded to offer consumers industry leading bedding and everyday essentials that are made with the greater good in mind. We directly source the world’s finest organic cotton to create luxuriously soft products, all while remaining rooted in fairness from farmer to factory worker. Bhumi offers luxuriously soft organic cotton bedding, sheets, towels and everyday clothing basics and activewear.

Register Interest

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now